Clinical Trial Update: Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy of a Cannabis Sativa Extract for spasticity in motor neuron disease and ALS. The study spans Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Drugs mentioned

• Cannabis Sativa Extract

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis (ALS) | Phase 2, Phase 3 | Status: COMPLETED